Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Sezary syndrome, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mycosis fungoides, neoplasm, primary cutaneous T-cell non-Hodgkin lymphoma	Active, not recruiting	Phase 2	2026-06-12		NCT04960618

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Memorial Sloan Kettering Cancer Center	753

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Columbia University	New York	United States	154
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)	Basking Ridge	United States	131
Memorial Sloan Kettering Bergen (Limited Protocol Activities)	Montvale	United States	184
Memorial Sloan Kettering Cancer Center (All protocol activities)	New York	United States	2
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)	Middletown	United States	186
Memorial Sloan Kettering Nassau (Limited Protocol Activities)	Uniondale	United States	120
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)	Commack	United States	55
Memorial Sloan Kettering Westchester (Limited Protocol Activities)	Harrison	United States	166